Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy

被引:33
|
作者
Bijman, Rik G. [1 ]
Breedveld, Sebastiaan [1 ]
Arts, Tine [1 ]
Astreinidou, Eleftheria [2 ]
de Jong, Martin A. [2 ]
Granton, Patrick V. [1 ]
Petit, Steven F. [1 ]
Hoogeman, Mischa S. [1 ]
机构
[1] Erasmus MC Canc Inst, Dept Radiat Oncol, POB 5201, NL-3008 AE Rotterdam, Netherlands
[2] LUMC, Dept Radiat Oncol, Leiden, Netherlands
关键词
COMPLICATION PROBABILITY; SETUP UNCERTAINTIES; RADIOTHERAPY; OPTIMIZATION; HEAD; ROBUSTNESS; RANGE;
D O I
10.1080/0284186X.2017.1355113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Proton therapy is becoming increasingly available, so it is important to apply objective and individualized patient selection to identify those who are expected to benefit most from proton therapy compared to conventional intensity modulated radiation therapy (IMRT). Comparative treatment planning using normal tissue complication probability (NTCP) evaluation has recently been proposed. This work investigates the impact of NTCP model and dose uncertainties on model-based patient selection. Material and Methods: We used IMRT and intensity modulated proton therapy (IMPT) treatment plans of 78 oropharyngeal cancer patients, which were generated based on automated treatment planning and evaluated based on three published NTCP models. A reduction in NTCP of more than a certain threshold (e.g. 10% lower NTCP) leads to patient selection for IMPT, referred to as 'nominal' selection. To simulate the effect of uncertainties in NTCP-model coefficients (based on reported confidence intervals) and planned doses on the accuracy of model-based patient selection, the Monte Carlo method was used to sample NTCP-model coefficients and doses from a probability distribution centered at their nominal values. Patient selection accuracy within a certain sample was defined as the fraction of patients which had similar selection in both the 'nominal' and 'sampled' scenario. Results: For all three NTCP models, the median patient selection accuracy was found to be above 70% when only NTCP-model uncertainty was considered. Selection accuracy decreased with increasing uncertainty resulting from differences between planned and delivered dose. In case of excessive dose uncertainty, selection accuracy decreased to 60%. Conclusion: Model and dose uncertainty highly influence the accuracy of model-based patient selection for proton therapy. A reduction of NTCP-model uncertainty is necessary to reach more accurate model-based patient selection.
引用
收藏
页码:1444 / 1450
页数:7
相关论文
共 50 条
  • [31] Robustness assessment of clinical adaptive proton and photon radiotherapy for oesophageal cancer in the model-based approach
    Visser, Sabine
    Ribeiro, Cassia O.
    Dieters, Margriet
    Mul, Veronique E.
    Niezink, Anne G. H.
    van der Schaaf, Arjen
    Knopf, Antje-Christin
    Langendijk, Johannes A.
    Korevaar, Erik W.
    Both, Stefan
    Muijs, Christina T.
    RADIOTHERAPY AND ONCOLOGY, 2022, 177 : 197 - 204
  • [32] A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for HDR brachytherapy
    Yousif, Yousif A. M.
    Osman, Alexander F., I
    Halato, Mohammed A.
    PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 2021, 44 (03) : 871 - 886
  • [33] A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation
    Lo, Wu-Chia
    Chang, Chih-Ming
    Wu, Chia-Yun
    Hsieh, Chen-Hsi
    Shueng, Pei-Wei
    Cheng, Po-Wen
    Liao, Li-Jen
    BMC CANCER, 2022, 22 (01)
  • [34] Model-based optimization of adaptive external counterpulsation therapy
    Weyer, Soeren
    Weber, Hannes
    Kleeberg, Christian
    Leonhardt, Steffen
    Teichmann, Daniel
    INTERNATIONAL JOURNAL OF MODELING SIMULATION AND SCIENTIFIC COMPUTING, 2016, 7 (02)
  • [35] A CT-based radiomics model for predicting feeding tube insertion in oropharyngeal cancer
    Chinnery, Tricia
    Lang, Pencilla
    Nichols, Anthony
    Mattonen, Sarah
    MEDICAL IMAGING 2022: COMPUTER-AIDED DIAGNOSIS, 2022, 12033
  • [36] A portfolio selection model based on the knapsack problem under uncertainty
    Vaezi, Fereshteh
    Sadjadi, Seyed Jafar
    Makui, Ahmad
    PLOS ONE, 2019, 14 (05):
  • [37] Patient selection for proton therapy: a radiobiological fuzzy Markov model incorporating robust plan analysis
    Austin, Annabelle M.
    Douglass, Michael J. J.
    Nguyen, Giang T.
    Penfold, Scott N.
    PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 2020, 43 (02) : 493 - 503
  • [38] Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection
    Vanneste, Ben G. L.
    Hoffmann, Aswin L.
    van Lin, Emile N.
    Van de Voorde, Lien
    Pinkawa, Michael
    Lambin, Philippe
    RADIOTHERAPY AND ONCOLOGY, 2016, 121 (01) : 118 - 123
  • [39] Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal Cancer
    Beesley, Lauren J.
    Shuman, Andrew G.
    Mierzwa, Michelle L.
    Bellile, Emily L.
    Rosen, Benjamin S.
    Casper, Keith A.
    Ibrahim, Mohannad
    Dermody, Sarah M.
    Wolf, Gregory T.
    Chinn, Steven B.
    Spector, Matthew E.
    de Jong, Robert J. Baatenburg
    Dronkers, Emilie A. C.
    Taylor, Jeremy M. G.
    JAMA NETWORK OPEN, 2021, 4 (08) : E2120055
  • [40] A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients
    Mirandola, Alfredo
    Russo, Stefania
    Bonora, Maria
    Vischioni, Barbara
    Camarda, Anna Maria
    Ingargiola, Rossana
    Molinelli, Silvia
    Ronchi, Sara
    Rossi, Eleonora
    Vai, Alessandro
    Iacovelli, Nicola Alessandro
    Thariat, Juliette
    Ciocca, Mario
    Orlandi, Ester
    CANCERS, 2022, 14 (11)